Group Effect in Full Replicate Design [RSABE / ABEL]

posted by GM – India, 2018-09-12 07:17 (1100 d 13:35 ago) – Posting: # 19267
Views: 5,788

Dear All,

Hope all are doing well.

We are conducting a BE study of Highly variable drug in patient population. This study will be conducted in 3 groups, which are seperated by one month from each other. There is no clarity in the guidance to check the group effect for this design.

Our doubt is, whether the group effect should be checked in the full replicate design or not?

If so, what are the fixed/random effets need to be checked in RSABE and ABE?

Kindly explain.

Best Regards,
GM

Complete thread:

Activity
 Admin contact
21,678 posts in 4,533 threads, 1,541 registered users;
online 6 (0 registered, 6 guests [including 4 identified bots]).
Forum time: Thursday 20:53 CEST (Europe/Vienna)

Ignorance more frequently begets confidence
than does knowledge.    Charles Darwin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5